Cancer Chemotherapy and Pharmacology

, Volume 10, Issue 3, pp 221–222

Therapeutic effect of vincristine, adriamycin and prednisolone (VAP) in angioimmunoblastic lymphadenopathy (AIL)

  • Abdallah S. Awidi
  • Musleh S. Tarawneh
  • Mahmoud S. Abu Khalaf
  • Mohammad S. Al Khateeb
  • Samir S. Amr
Short Communication VAP Angioimmunoblastic Lymphadenopathy

DOI: 10.1007/BF00255768

Cite this article as:
Awidi, A.S., Tarawneh, M.S., Abu Khalaf, M.S. et al. Cancer Chemother. Pharmacol. (1983) 10: 221. doi:10.1007/BF00255768

Summary

Five patients, three males and two females, with angioimmunoblastic lymphadenopathy (AIL) are described. The two who received steroids had no response and died 2 and 6 months later. The three patients who received vincristine, adriamycin and prednisolone (VAP) went into remission early and are still in remission with a follow-up of 22–35 months. It is concluded that VAP is effective therapy in AIL.

Copyright information

© Springer-Verlag 1983

Authors and Affiliations

  • Abdallah S. Awidi
    • 1
  • Musleh S. Tarawneh
    • 2
  • Mahmoud S. Abu Khalaf
    • 3
  • Mohammad S. Al Khateeb
    • 4
  • Samir S. Amr
    • 2
  1. 1.Department of Internal MedicineJordan University HospitalAmmanJordan
  2. 2.Department of PathologyJordan University HospitalAmmanJordan
  3. 3.Department of SurgeryJordan University HospitalAmmanJordan
  4. 4.Department of MicrobiologyJordan University HospitalAmmanJordan